Franklin Resources’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-34,737
| Closed | -$546K | – | 3000 |
|
|
2024
Q1 | $546K | Buy |
+34,737
| New | +$535K | ﹤0.01% | 2199 |
|
|
2023
Q3 | – | Sell |
-10,942
| Closed | -$154K | – | 2813 |
|
|
2023
Q2 | $154K | Sell |
10,942
-10
| -0.1% | -$143 | ﹤0.01% | 2448 |
|
|
2023
Q1 | $169K | Buy |
10,952
+10
| +0.1% | +$167 | ﹤0.01% | 2033 |
|
|
2022
Q4 | $179K | Buy |
+10,942
| New | +$178K | ﹤0.01% | 2023 |
|
|
2022
Q2 | – | Sell |
-13,317
| Closed | -$123K | – | 2492 |
|
|
2022
Q1 | $123K | Buy |
+13,317
| New | +$113K | ﹤0.01% | 2258 |
|
|
2021
Q4 | – | Sell |
-3,195,854
| Closed | -$109M | – | 2569 |
|
|
2021
Q3 | $109M | Buy |
3,195,854
+139,641
| +5% | +$4.46M | 0.04% | 450 |
|
|
2021
Q2 | $112M | Sell |
3,056,213
-784,521
| -20% | -$30.4M | 0.04% | 439 |
|
|
2021
Q1 | $172M | Buy |
3,840,734
+253,895
| +7% | +$11.8M | 0.07% | 303 |
|
|
2020
Q4 | $205M | Buy |
3,586,839
+204,288
| +6% | +$12.1M | 0.09% | 258 |
|
|
2020
Q3 | $174M | Sell |
3,382,551
-148,937
| -4% | -$7.3M | 0.08% | 254 |
|
|
2020
Q2 | $175M | Buy |
3,531,488
+294,105
| +9% | +$15.7M | 0.09% | 253 |
|
|
2020
Q1 | $133M | Buy |
3,237,383
+864,661
| +36% | +$48M | 0.09% | 246 |
|
|
2019
Q4 | $148M | Buy |
2,372,722
+1,562,662
| +193% | +$74.3M | 0.08% | 287 |
|
|
2019
Q3 | $27.5M | Buy |
+810,060
| New | +$24M | 0.01% | 672 |
|
|
2018
Q1 | – | Sell |
-250,000
| Closed | -$5.67M | – | 1555 |
|
|
2017
Q4 | $5.67M | Hold |
250,000
| – | – | ﹤0.01% | 1048 |
|
|
2017
Q3 | $4.75M | Buy |
+250,000
| New | +$4.58M | ﹤0.01% | 1065 |
|
Other funds holding DCPH
Franklin Resources's DCPH Position: Q2 2024 in Review
Franklin Resources sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 34,737 shares — an estimated $546K sold.
Franklin Resources first reported a position in DCPH in Q3 2017 and held it in 16 quarters. The position peaked at $205M in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Franklin Resources reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Franklin Resources sold 34,737 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $546K.
- Franklin Resources first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 16 quarters.
- Franklin Resources's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $205M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Franklin Resources's 13F filing for Q2 2024, filed 14 Aug 2024.